GlaxoSmithKline (GSK) stock forecast for 2023. Forecast tables and graphs.

GlaxoSmithKline (GSK) stock forecast for 2023

The forecast has been updated: June 9, 2021 14:08


GlaxoSmithKline stock price online today

Analyst Target Price

47.27

Dividend Date

08.07.2021

Ex Dividend Date

20.05.2021

Last Split Factor

2:1

Last Split Date

12.11.1991

Should you buy or sell GlaxoSmithKline stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? GlaxoSmithKline stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $47.27 target price for GlaxoSmithKline stock stock.

Today 200 Day Moving Average is the support level (36.9973 $).

50 Day Moving Average is the resistance level (38.3562 $).




GSK Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 44.22 43.51 45.16 3.67 %
Feb 45.04 44.16 45.83 3.64 %
Mar 45.36 44.40 45.96 3.39 %
Apr 45.39 44.54 46.69 4.59 %
May 44.07 43.52 45.32 3.98 %
Jun 43.59 43.08 44.11 2.35 %
Jul 44.86 43.48 46.21 5.91 %
Aug 45.96 45.32 47.25 4.10 %
Sep 47.29 46.18 48.54 4.86 %
Oct 46.46 46.08 47.26 2.49 %
Nov 45.46 44.15 46.65 5.36 %
Dec 45.92 45.31 46.91 3.40 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GlaxoSmithKline stock.


GlaxoSmithKline overview

GlaxoSmithKline Address

980 Great West Road, Brentford, United Kingdom, TW8 9GS

Market Capitalization

96 380 354 560 $

EBITDA

9 715 999 744

PE Ratio

13.1504

PEG Ratio

4.5557

Dividend Per Share

0.8

Dividend Yield

0.0206

EPS

2.952

Quarterly Earnings Growth YOY

-0.317

Quarterly Revenue Growth YOY

-0.184

Trailing PE

13.1504

Forward PE

14.0252

EV To Revenue

3.8956

EV To EBITDA

12.6361

52 Week High

40.0901

52 Week Low

31.82

50 Day Moving Average

38.3562

200 Day Moving Average

36.9973

Shares Outstanding

2515749888

Shares Float

2445716550

Shares Short Prior Month

28197543

Short Ratio

4.82

Percent Insiders

0.013

Percent Institutions

12.58

GlaxoSmithKline stock forecast for this year


GlaxoSmithKline stock forecast for Jan 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 44.22. Positive monthly dynamics of the instrument is expected with 3.665% volatility is expected.

Pessimistic forecast: 43.51

Optimistic: 45.16


GlaxoSmithKline stock forecast for Feb 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 45.04. Positive monthly dynamics of the instrument is expected with 3.641% volatility is expected.

Pessimistic forecast: 44.16

Optimistic: 45.83


GlaxoSmithKline stock forecast for Mar 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 45.36. Positive monthly dynamics of the instrument is expected with 3.387% volatility is expected.

Pessimistic forecast: 44.40

Optimistic: 45.96


GlaxoSmithKline stock forecast for Apr 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 45.39. Positive monthly dynamics of the instrument is expected with 4.588% volatility is expected.

Pessimistic forecast: 44.54

Optimistic: 46.69


GlaxoSmithKline stock forecast for May 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 44.07. Negative monthly dynamics of the instrument is expected with 3.982% volatility is expected.

Pessimistic forecast: 43.52

Optimistic: 45.32


GlaxoSmithKline stock forecast for Jun 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 43.59. Negative monthly dynamics of the instrument is expected with 2.351% volatility is expected.

Pessimistic forecast: 43.08

Optimistic: 44.11


GlaxoSmithKline stock forecast for Jul 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 44.86. Positive monthly dynamics of the instrument is expected with 5.907% volatility is expected.

Pessimistic forecast: 43.48

Optimistic: 46.21


GlaxoSmithKline stock forecast for Aug 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 45.96. Positive monthly dynamics of the instrument is expected with 4.097% volatility is expected.

Pessimistic forecast: 45.32

Optimistic: 47.25


GlaxoSmithKline stock forecast for Sep 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 47.29. Positive monthly dynamics of the instrument is expected with 4.863% volatility is expected.

Pessimistic forecast: 46.18

Optimistic: 48.54


GlaxoSmithKline stock forecast for Oct 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 46.46. Negative monthly dynamics of the instrument is expected with 2.492% volatility is expected.

Pessimistic forecast: 46.08

Optimistic: 47.26


GlaxoSmithKline stock forecast for Nov 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 45.46. Negative monthly dynamics of the instrument is expected with 5.359% volatility is expected.

Pessimistic forecast: 44.15

Optimistic: 46.65


GlaxoSmithKline stock forecast for Dec 2023.
Estimated Average Forecasted GlaxoSmithKline Price: 45.92. Positive monthly dynamics of the instrument is expected with 3.398% volatility is expected.

Pessimistic forecast: 45.31

Optimistic: 46.91



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 110.48 (14.06.2021) 0.52 %
AbbVie Inc.
ABBV 115.4 (14.06.2021) -0.02 %
Aeterna Zentaris Inc.
AEZS 1.02 (14.06.2021) -2.86 %
Allakos Inc.
ALLK 90.87 (14.06.2021) -3.24 %
Allogene Therapeutics, Inc.
ALLO 25.37 (14.06.2021) -2.80 %
Amgen Inc.
AMGN 241.19 (14.06.2021) -0.65 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (14.06.2021) 1.81 %
Aurora Cannabis Inc.
ACB 9.67 (14.06.2021) -1.53 %
Becton Dickinson and Company
BDX 242.72 (14.06.2021) 0.03 %
Biogen Inc.
BIIB 406.14 (14.06.2021) 2.40 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 100.4 (14.06.2021) -4.40 %
BioNTech SE
BNTX 220.58 (14.06.2021) -7.53 %
bluebird bio, Inc.
BLUE 33.53 (14.06.2021) -1.67 %
Boston Scientific Corp.
BSX 42.54 (14.06.2021) -0.86 %
Bristol-Myers Squibb Company
BMY 67.29 (14.06.2021) -0.07 %
Canopy Growth Corp.
CGC 25.14 (14.06.2021) -2.82 %
Castle Biosciences, Inc.
CSTL 71.86 (14.06.2021) -0.04 %
Eli Lilly and Company
LLY 226.1 (14.06.2021) 0.90 %
Emergent BioSolutions Inc.
EBS 61.79 (14.06.2021) -2.71 %
Exelixis, Inc.
EXEL 22.76 (14.06.2021) -0.96 %
G1 Therapeutics, Inc.
GTHX 22.75 (14.06.2021) 5.23 %
Gilead Sciences, Inc.
GILD 68.15 (14.06.2021) -0.90 %
GlaxoSmithKline plc
GSK 40.49 (14.06.2021) 0.85 %
GoodRx Holdings, Inc.
GDRX 38.33 (14.06.2021) 4.21 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 82.64 (14.06.2021) 0.07 %
Inovio Pharmaceuticals, Inc.
INO 8.63 (15.06.2021) -3.14 %
Johnson & Johnson
JNJ 165.37 (14.06.2021) 0.25 %
Medtronic plc.
MDT 124.15 (14.06.2021) 0.30 %
Merck & Co., Inc.
MRK 75.45 (14.06.2021) -1.08 %
Moderna, Inc.
MRNA 207.41 (14.06.2021) -5.23 %
Novartis AG
NVS 93.59 (14.06.2021) 0.97 %
Novavax, Inc.
NVAX 207.71 (14.06.2021) -0.94 %
ObsEva SA
OBSV 3.17 (14.06.2021) -0.63 %
OrganiGram Holdings Inc.
OGI 3.08 (15.06.2021) -1.91 %
Pfizer Inc.
PFE 39.63 (14.06.2021) -1.30 %
Regeneron Pharmaceuticals, Inc.
REGN 528.75 (14.06.2021) 0.61 %
Sanofi
SNY 54.25 (14.06.2021) 0.84 %
Schrodinger, Inc.
SDGR 76.34 (14.06.2021) -1.51 %
Senseonics Holdings, Inc.
SENS 3.96 (14.06.2021) -1.25 %
Sorrento Therapeutics, Inc.
SRNE 9.46 (14.06.2021) 6.65 %
Stryker Corp.
SYK 255.69 (14.06.2021) -0.04 %
Sundial Growers Inc.
SNDL 1.06 (14.06.2021) 0.95 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 11.05 (14.06.2021) -0.54 %
Thermo Fisher Scientific Inc.
TMO 470.07 (14.06.2021) 1.06 %
Tilray, Inc.
TLRY 19.16 (14.06.2021) -3.67 %
UnitedHealth Group, Inc.
UNH 399.16 (14.06.2021) 0.32 %
Veeva Systems Inc.
VEEV 303.9 (14.06.2021) 1.57 %
Zomedica Corp.
ZOM 0.9458 (14.06.2021) -0.08 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.66 (14.06.2021) 0.35 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.